Artículos por temáticas

Management of Spastic Paresis and Cervical Dystonia: access to Therapeutic Innovations Through an International Program of Practical Courses.

Colosimo C, Bhidayasiri R, Fheodoroff K, Bhatia K, Chung TM, Landreau T, Jacinto LJ.

Clin Ther. 2019 Oct 10. pii: S0149-2918(19)30484-9. doi: 10.1016/j.clinthera.2019.09.007. [Epub ahead of print]

Clinical outcomes of pallidal deep brain stimulation for dystonia implanted using intraoperative MRI.

Sharma VD, Bezchlibnyk YB, Isbaine F, Naik KB, Cheng J, Gale JT, Miocinovic S, Buetefisch C, Factor SA, Willie JT, Boulis NM, Wichmann T, DeLong MR, Gross RE.

J Neurosurg. 2019 Oct 11:1-13. doi: 10.3171/2019.6.JNS19548. [Epub ahead of print]

Epidemiology of DYT1 dystonia: Estimating prevalence via genetic ascertainment.

Park J, Damrauer SM, Baras A, Reid JG, Overton JD, Gonzalez-Alegre P.

Neurol Genet. 2019 Sep 13;5(5):e358. doi: 10.1212/NXG.0000000000000358. eCollection 2019 Oct.

Quantitative Assessment of Head Tremor in Patients with Essential Tremor and Cervical Dystonia by Using Inertial Sensors.

Berbakov L, Jovanović Č, Svetel M, Vasiljević J, Dimić G, Radulović N.

Sensors (Basel). 2019 Sep 30;19(19). pii: E4246. doi: 10.3390/s19194246.

Visual sensory processing is altered in myoclonus dystonia

Tarrano C, Wattiez N, Delorme C, McGovern EM, Brochard V, Thobois S, Tranchant C, Grabli D, Degos B, Corvol JC, Pedespan JM, Krystkoviak P, Houeto JL, Degardin A, Defebvre L, Valabrègue R, Vidailhet M

Mov Disord. 2020 Jan;35(1):151-160. doi: 10.1002/mds.27857. Epub 2019 Sep 30.

Validation of a self-completed Dystonia Non-Motor Symptoms Questionnaire.

Klingelhoefer L, Chaudhuri KR, Kamm C, Martinez-Martin P, Bhatia K, Sauerbier A, Kaiser M, Rodriguez-Blazquez C, Balint B, Untucht R, Hall LJ, Mildenstein L, Wienecke M, Martino D, Gregor O, Storch A,

Ann Clin Transl Neurol. 2019 Oct;6(10):2054-2065. doi: 10.1002/acn3.50900. Epub 2019 Sep 27.

Cerebellar Involvement in DYT-THAP1 Dystonia.

Nikolov P, Hassan SS, Aytulun A, Hartmann CJ, Kohlhase J, Schnitzler A, Albrecht P, Minnerop M, Groiss SJ.

Cerebellum. 2019 Oct;18(5):969-971. doi: 10.1007/s12311-019-01062-0.

Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration.

Sava V, Fihurka O, Khvorova A, Sanchez-Ramos J.

Nanomedicine. 2019 Oct 27:102119. doi: 10.1016/j.nano.2019.102119. [Epub ahead of print]

Multidisciplinary rehabilitation reduces hypothalamic grey matter volume loss in individuals with preclinical Huntington's disease: A nine-month pilot study.

Bartlett DM, Dominguez D JF, Lazar AS, Kordsachia CC, Rankin TJ, Lo J, Govus AD, Power BD, Lampit A, Eastwood PR, Ziman MR, Cruickshank TM.

J Neurol Sci. 2019 Oct 13;408:116522. doi: 10.1016/j.jns.2019.116522. [Epub ahead of print]

Motor speech patterns in Huntington disease.

Diehl SK, S Mefferd A, Lin YC, Sellers J, E McDonell K, de Riesthal M, Claassen DO.

Neurology. 2019 Oct 29. pii: 10.1212/WNL.0000000000008541. doi: 10.1212/WNL.0000000000008541. [Epub ahead of print]

Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.

Ringkøbing SP, Larsen IU, Jørgensen K, Vinther-Jensen T, Vogel A.

J Huntingtons Dis. 2019 Oct 21. doi: 10.3233/JHD-190350. [Epub ahead of print]

Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration.

Ardan T, Baxa M, Levinská B, Sedláčková M, Nguyen TD, Klíma J, Juhás Š, Juhásová J, Šmatlíková P, Vochozková P, Motlík J, Ellederová Z.

Dis Model Mech. 2019 Oct 23. pii: dmm.041319. doi: 10.1242/dmm.041319. [Epub ahead of print]

Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.

Carbo M, Brandi V, Pascarella G, Staid DS, Colotti G, Polticelli F, Ilari A, Morea V.

Int J Mol Med. 2019 Oct 15. doi: 10.3892/ijmm.2019.4373. [Epub ahead of print]

Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington's disease.

Elifani F, Amico E, Pepe G, Capocci L, Castaldo S, Rosa P, Montano E, Pollice A, Madonna M, Filosa S, Calogero A, Maglione V, Crispi S, Di Pardo A.

Hum Mol Genet. 2019 Oct 20. pii: ddz247. doi: 10.1093/hmg/ddz247. [Epub ahead of print]

Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis.

Altinoz MA, Ozpinar A, Ozpinar A, Hacker E.

Metab Brain Dis. 2019 Oct 17. doi: 10.1007/s11011-019-00500-6. [Epub ahead of print] Review.